Investing.com - Walvax BioTech reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Walvax BioTech announced earnings per share of ¥0.07 on revenue of ¥1.36. Analysts polled by Investing.com anticipated EPS of ¥0.18 on revenue of ¥1.55B.
Walvax BioTech shares are up 50% from the beginning of the year , still down 48.65% from its 52 week high of ¥72.83 set on Monday, November 29, 2021.
Walvax BioTech shares lost 3.23% in intra-day trade the report.
Walvax BioTech follows other major Healthcare sector earnings this month
Walvax BioTech's report follows an earnings missed by Top Choice Medical Investment on Tuesday, who reported EPS of ¥0.68 on revenue of ¥821.2M, compared to forecasts EPS of ¥0.95 on revenue of ¥1.08B.
Autek China had beat expectations on Saturday with third quarter EPS of ¥0.28 on revenue of ¥526.7M, compared to forecast for EPS of ¥0.2532 on revenue of ¥587.16M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar